Harvard Bioscience Inc (HBIO) support and resistance · rev $22.7M
Harvard Bioscience Inc (HBIO) is a medical instruments & supplies company listed on US.
This page maps Harvard Bioscience Inc (HBIO) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported HBIO revenue for 2026-06-30 was $22.7M. Net income was -$2.9M. Revenue was up 9.5% from 2026-03-31 to 2026-06-30. HBIO currently screens at market cap $20.3M.
HBIO currently screens at market cap $20.3M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new HBIO 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the HBIO quote page for the session range and the stock page for the full model.
Not investment advice.